Extracorporeal Carbon Dioxide Removal in the Treatment of Status Asthmaticus
- PMID: 33031151
- DOI: 10.1097/CCM.0000000000004645
Extracorporeal Carbon Dioxide Removal in the Treatment of Status Asthmaticus
Abstract
Objectives: Venovenous extracorporeal carbon dioxide removal may be lifesaving in the setting of status asthmaticus.
Design: Retrospective review.
Setting: Medical ICU.
Patients: Twenty-six adult patients with status asthmaticus treated with venovenous extracorporeal carbon dioxide removal.
Interventions: None.
Measurements and main results: Demographic data and characteristics of current and prior asthma treatments were obtained from the electronic medical record. Mechanical ventilator settings, arterial blood gases, vital signs, and use of vasopressors were collected from the closest time prior to cannulation and 24 hours after initiation of extracorporeal carbon dioxide removal. Extracorporeal carbon dioxide removal settings, including blood flow and sweep gas flow, were collected at 24 hours after initiation of extracorporeal carbon dioxide removal. Outcome measures included rates of survival to hospital discharge, ICU and hospital lengths of stay, duration of invasive mechanical ventilation and extracorporeal carbon dioxide removal support, and complications during extracorporeal carbon dioxide removal. Following the initiation of extracorporeal carbon dioxide removal, blood gas values were significantly improved at 24 hours, as were peak airway pressures, intrinsic positive end-expiratory pressure, and use of vasopressors. Survival to hospital discharge was 100%. Twenty patients (76.9%) were successfully extubated while receiving extracorporeal carbon dioxide removal support; none required reintubation. The most common complication was cannula-associated deep venous thrombosis (six patients, 23.1%). Four patients (15.4%) experienced bleeding that required a transfusion of packed RBCs.
Conclusions: In the largest series to date, use of venovenous extracorporeal carbon dioxide removal in patients with status asthmaticus can provide a lifesaving means of support until the resolution of the exacerbation, with an acceptably low rate of complications. Early extubation in select patients receiving extracorporeal carbon dioxide removal is safe and feasible and avoids the deleterious effects of positive-pressure mechanical ventilation in this patient population.
Comment in
-
Extracorporeal Carbon Dioxide Removal or Extracorporeal Membrane Oxygenation: Why Should We Care?Crit Care Med. 2021 May 1;49(5):e546-e547. doi: 10.1097/CCM.0000000000004844. Crit Care Med. 2021. PMID: 33854019 No abstract available.
-
The authors reply.Crit Care Med. 2021 May 1;49(5):e548-e549. doi: 10.1097/CCM.0000000000004959. Crit Care Med. 2021. PMID: 33854020 No abstract available.
-
What Is the Best Extracorporeal Carbon Dioxide Removal Blood Flow to Help Treating Patients With Severe Status Asthmaticus!Crit Care Med. 2021 Oct 1;49(10):e1061-e1062. doi: 10.1097/CCM.0000000000005101. Crit Care Med. 2021. PMID: 34529632 No abstract available.
References
-
- Moorman JE, Akinbami LJ, Bailey CM, et al.: National surveillance of asthma: United States, 2001-2010. Vital Health Stat. 2012;35:1–58.
-
- Krishnan V, Diette GB, Rand CS, et al.: Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med. 2006; 174:633–638.
-
- Serrano-Pariente J, Plaza V: Near-fatal asthma: A heterogeneous clinical entity. Curr Opin Allergy Clin Immunol. 2017; 17:28–35.
-
- Kenyon N, Zeki AA, Albertson TE, et al.: Definition of critical asthma syndromes. Clin Rev Allergy Immunol. 2015; 48:1–6.
-
- Leatherman J: Mechanical ventilation for severe asthma. Chest. 2015; 147:1671–1680.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
